Investigating the therapeutic inhibition of CXCR2 as a disease modifying treatment for motor neurone disease (2020–2021)

Grant type:
Motor Neurone Disease Research Institute of Australia Inc
Researchers:
Funded by:
Motor Neurone Disease Research Institute of Australia Inc